Editorial: Interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset still's disease?

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1072-1076

  Canna, Scott W ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY;

ADAPTIVE IMMUNITY; ADULT ONSET STILL DISEASE; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC DISEASE; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

ANIMALS; ARTHRITIS, JUVENILE; DISEASE MODELS, ANIMAL; FEMALE; FREUND'S ADJUVANT; IMMUNE SYSTEM; INTERFERON-GAMMA; MALE;

EID: 84899742361     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38362     Document Type: Review

References (17)

1. Montealegre Sanchez GA, Almeida de Jesus A, Goldbach-Mansky R,. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am 2013; 39: 701-34.
2. Crispin JC, Martinez-Banos D, Alcocer-Varela J,. Adult-onset Still disease as the cause of fever of unknown origin. Medicine (Baltimore) 2005; 84: 331-7.
3. Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I, et al. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006; 25: 639-44.
4. Behrens EM, Beukelman T, Paessler M, Cron RQ,. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007; 34: 1133-8.
5. Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007; 56: 3793-804.
6. Gattorno M, Piccini A, Lasiglie D, Tassi S, Brisca G, Carta S, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 1505-15.
7. Shimizu M, Nakagishi Y, Yachie A,. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 2013; 61: 345-8.
8. Ichida H, Kawaguchi Y, Sugiura T, Takagi K, Katsumata Y, Gono T, et al. Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and IL-18. Arthritis Care Res (Hoboken) 2014; 66: 642-6.
9. Avau A, Mitera T, Put S, Put K, Brisse E, Filtjens J, et al. Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-γ. Arthritis Rheumatol 2014; 66: 1340-51.
10. Kelchtermans H, Billiau A, Matthys P,. How interferon-γ keeps autoimmune diseases in check. Trends Immunol 2008; 29: 479-86.
11. Strippoli R, Carvello F, Scianaro R, De Pasquale L, Vivarelli M, Petrini S, et al. Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome. Arthritis Rheum 2012; 64: 1680-8.
12. Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 2011; 121: 2264-77.
13. Canna SW, Wrobel J, Chu N, Kreiger PA, Paessler M, Behrens EM,. Interferon-γ mediates anemia but is dispensable for fulminant Toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum 2013; 65: 1764-75.
14. Ohyagi H, Onai N, Sato T, Yotsumoto S, Liu J, Akiba H, et al. Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity 2013; 39: 584-98.
15. Pachlopnik Schmid J, Cote M, Menager MM, Burgess A, Nehme N, Menasche G, et al. Inherited defects in lymphocyte cytotoxic activity. Immunol Rev 2010; 235: 10-23.
16. Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 2011; 208: 1203-14.
17. Krebs P, Crozat K, Popkin D, Oldstone MB, Beutler B,. Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood 2011; 117: 6582-8.